Fiera Capital (Canada)’s Array Biopharma Inc ARRY Stock Holding History

Fiera Capital (Canada)’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-71,142	Closed	-$3.3M	–	700
2019 Q2	$3.3M	Sell	71,142 -1,772,078	-96%	-$49.8M	0.01%	306
2019 Q1	$44.9M	Buy	1,843,220 +435,147	+31%	+$9.06M	0.18%	107
2018 Q4	$20.1M	Buy	1,408,073 +1,135,896	+417%	+$17.2M	0.09%	164
2018 Q3	$4.14M	Sell	272,177 -8,494	-3%	-$130K	0.02%	318
2018 Q2	$4.71M	Buy	280,671 +113,636	+68%	+$1.81M	0.02%	313
2018 Q1	$2.73M	Buy	+167,035	New	+$2.68M	0.01%	358

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Fiera Capital (Canada)'s ARRY Position: Q3 2019 in Review

Fiera Capital (Canada) sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 71,142 shares — an estimated $3.3M sold.

Fiera Capital (Canada) first reported a position in ARRY in Q1 2018 and held it in 6 quarters. The position peaked at $44.9M in Q1 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Fiera Capital (Canada) reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Fiera Capital (Canada) sold 71,142 Array Biopharma Inc shares in Q3 2019, an estimated $3.3M.
Fiera Capital (Canada) first reported a position in Array Biopharma Inc in Q1 2018 and held it in 6 quarters.
Fiera Capital (Canada)'s Array Biopharma Inc position peaked at $44.9M in Q1 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Fiera Capital (Canada)'s 13F filing for Q3 2019, filed 12 Nov 2019.